Epub 2006 May 15.
Conventional systemic agents for psoriasis. A systematic review
Affiliations
- PMID: 16724368
Item in Clipboard
Conventional systemic agents for psoriasis. A systematic review
J Rheumatol.
2006 Jul.
Abstract
Very few well designed studies have evaluated the conventional systemic agents for psoriasis. This is a systematic, evidence-based review of the literature evaluating both the efficacy and safety of the medications cyclosporine, methotrexate, acitretin, hydroxyurea, and 6-thioguanine. Treatment recommendations are made.
Similar articles
-
Current and future oral systemic therapies for psoriasis.Dermatol Clin. 2015 Jan;33(1):91-109. doi: 10.1016/j.det.2014.09.008. Dermatol Clin. 2015. PMID: 25412786 Review.
-
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. doi: 10.3310/hta10460. Health Technol Assess. 2006. PMID: 17083854
-
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.Cochrane Database Syst Rev. 2022 Oct 31;10(10):CD014831. doi: 10.1002/14651858.CD014831.pub2. Cochrane Database Syst Rev. 2022. PMID: 36315029 Free PMC article.
-
Current systemic therapies for psoriasis: where are we now?J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S66-77. doi: 10.1016/mjd.2003.550. J Am Acad Dermatol. 2003. PMID: 12894129 Review.
-
Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability.Arch Dermatol. 2000 Dec;136(12):1536-43. doi: 10.1001/archderm.136.12.1536. Arch Dermatol. 2000. PMID: 11115167
Cited by
-
IL-10 implications in psoriasis.Int J Health Sci (Qassim). 2008 Jan;2(1):53-8. Int J Health Sci (Qassim). 2008. PMID: 21475472 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2023 Jul 12;7:CD011535. doi: 10.1002/14651858.CD011535.pub6. PMID: 35603936 Free PMC article. Updated.
-
Efalizumab in the treatment of psoriasis.Biologics. 2007 Sep;1(3):301-9. Biologics. 2007. PMID: 19707339 Free PMC article.
-
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii2-22. doi: 10.1136/ard.2007.081430. Ann Rheum Dis. 2007. PMID: 17934088 Free PMC article. Review. No abstract available.
-
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis.Core Evid. 2010 Jul 27;5:11-22. doi: 10.2147/ce.s5994. Core Evid. 2010. PMID: 20694136 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
